Substance-induced psychoses (SIP) may offer a useful vantage point for exploring mechanisms underlying psychotic disorders and for examining the phenomenological specificities of schizophrenia. Clinical observations suggest that a clinically relevant subset of patients does not fully recover after an episode of substance-induced psychosis, raising the hypothesis of more persistent psychotic trajectories that may differ from both acute SIP and primary psychotic disorders (PPD). In this context, the proposal of Substance-Related Exogenous Psychosis (SREP) situates exogenous psychoses as conditions related to, yet not fully overlapping with, schizophrenia. Drawing on the tradition of classical psychopathology, from Bonhoeffer’s exogenous model to the concept of lysergic psychoma, and integrating it with recent research on self-disorders, the hypothesis emerges that substance-induced psychoses may function as heuristic phenomenological models useful for exploring the genesis of psychotic phenomena. Examination of ipseity through the EASE interview suggest similarities between SIP and PPD, but also significant differences: SIP are characterized by more superficial and transient alterations of the self, whereas schizophrenia involves deeper and structurally embedded disturbances. From this perspective, the phenomenological comparison of schizophrenia, SIP, and SREP may help delineate with greater precision which dimensions of self-experience are compromised across these psychotic conditions. This conceptual framework is intended as a hypothesis-generating perspective, which may guide future longitudinal studies integrating phenomenology and substance-related mechanisms to refine the boundaries between acute SIP, persistent SIP/SREP trajectories, and schizophrenia spectrum disorders.
- Open Access
- Opinion
Can Substance-Induced Psychoses (SIP) Shed Light on the Paradigm of Schizophrenia?
Author Information
Received: 03 Dec 2025 | Revised: 01 Feb 2026 | Accepted: 06 Feb 2026 | Published: 10 Mar 2026
Abstract
Keywords
substance-induced psychosis (SIP) | schizophrenia | ipseity | self-disorders | anomalous self-experience (EASE) | phenomenological psychopathology
References
- 1.
Caton, C.L.; Drake, R.E.; Hasin, D.S.; et al. Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses. Arch. Gen. Psychiatry 2005, 62, 137–145.
- 2.
Chiappini, S.; Mosca, A.; Semeraro, F.; et al. Navigating the challenges of substance use and psychopathology in depression, bipolar disorder, and schizophrenia. Compr. Psychiatry 2025, 142, 152616. https://doi.org/10.1016/j.comppsych.2025.152616.
- 3.
Ricci, V.; Aragona, M.; Maina, G.; et al. Phenomenology of hallucinations in endogenous and substance-related exogenous psychoses. Psychopathology 2025, 30, 1–21. https://doi.org/10.1159/000547087.
- 4.
Martinotti, G.; Chiappini, S.; Mosca, A.; et al. Atypical Antipsychotic Drugs in Dual Disorders: Current Evidence for Clinical Practice. Curr. Pharm. Des. 2022, 28, 2241–2259. https://doi.org/10.2174/1381612828666220623092853.
- 5.
Mosca, A.; Chiappini, S.; Miuli, A.; et al. Clinical Management of Synthetic-Cannabinoid-Induced Psychosis: A Systematic Review of Treatment Strategies and Outcomes. Brain Sci. 2025, 15, 1006. https://doi.org/10.3390/brainsci15091006.
- 6.
Kalayasiri, R.; Verachai, V.; Gelernter, J.; et al. Clinical features of methamphetamine-induced paranoia and preliminary genetic association with DBH-1021C→T in a Thai treatment cohort. Addiction 2014, 109, 965–976.
- 7.
Sabé, M.; Sulstarova, A.; Glangetas, A.; et al. Reconsidering evidence for psychedelic-induced psychosis: An overview of reviews, a systematic review, and meta-analysis of human studies. Mol. Psychiatry 2025, 30, 1223–1255. https://doi.org/10.1038/s41380-024-02800-5.
- 8.
Mosca, A.; Mancusi, G.; Chiappini, S.; et al. Novel psychoactive substances (NPS) as a risk factor for psychosis: A systematic review of the literature. Neurosci. Biobehav. Rev. 2025, 179, 106431. https://doi.org/10.1016/j.neubiorev.2025.106431.
- 9.
Papanti, D.; Schifano, F.; Botteon, G.; et al. “Spiceophrenia”: A systematic overview of “spice”-related psychopathological issues and a case report. Hum. Psychopharmacol. Clin. Exp. 2013, 28, 379–389. https://doi.org/10.1002/hup.2312.
- 10.
Martinotti, G.; De Risio, L.; Vannini, C.; et al. Substance-related exogenous psychosis: A postmodern syndrome. CNS Spectr. 2021, 26, 84–91.
- 11.
Bonhoeffer, K. Der Geisteszustand des Alkoholdeliranten; Maretzke & Märtin: Trzebnica, Poland, 1897.
- 12.
Bleuler, E. Die Prognose der Dementia praecox (Schizophreniegruppe). Allg. Z. Psychiat. 1908, 65, 436–464.
- 13.
Bonhoeffer, K. Zur Frage der Klassifikation der sympomatischen Psychosen. Berl. Klin. Wochenschr. 1908, 45, 2257–2260.
- 14.
Bonhoeffer, K. Klinische und anatomische Beitrage zur Kenntnis der Alkoholdelirien. Mschr. Psychiat. Neurol. 1897, 1, 6–41.
- 15.
Angrist, B.M.; Gershon, S. The phenomenology of experimentally induced am- phetamine psychosis—Preliminary observations. Biol. Psychiatry 1970, 2, 95–107.
- 16.
Mathias, S.; Lubman, D.I.; Hides, L. Substance-induced psychosis: A diagnostic conundrum. J. Clin. Psychiatry 2008, 69, 358–367.
- 17.
De Giacomo, U.; Morselli, G. E.; Cargnello, D.; et al. Le Psicosi Sperimentali; Feltrinelli: Milano, Italy, 1962
- 18.
Di Petta, G.; Tittarelli, D. Le Psicosi Sintetiche. Il Contributo Della Psicopatologia Fenomenologica Italiana Alle Psicosi Indotte da Sostanze; Feltrinelli: Milano, Italy, 2016.
- 19.
Ricci, V.; Maina, G.; Di Petta, G.; Martinotti, G. The Resurgence of Exogenous Psychosis: A Phenomenological Examination of Substance-Induced Psychopathology. J. Nerv. Ment. Dis. 2024, 212, 457–459. https://doi.org/10.1097/NMD.0000000000001800.
- 20.
Beringer, K. Der Meskalinrausch. Seine Geschichte und Erscheinungsweise; Springer-Verlag Berlin Heidelberg GmbH, Berlin, Germany, 1927.
- 21.
Morselli, G.E. Expérience mescalinique et vécu schizophrénique. L’Evolution Psychiatr. 1959, 275.
- 22.
Morselli, G.E. Neuropsychiatry & Experimental Psychiatry. In Proceedings of the Comunicazione al II Congresso Internazionale, Londra, UK, 29 July–2 August 1935.
- 23.
Morselli, G.E. Mescalina e schizofrenia. Riv. Psicol. 1945, 3.
- 24.
Sass, L.A.; Parnas, J. Schizophrenia, consciousness, and the self. Schizophr. Bull. 2003, 29, 427–444.
- 25.
Sass, L.A. Self-disturbance and schizophrenia: Structure, specificity, pathogenesis (current issues, new directions). Schizophr. Res. 2014, 152, 5–11.
- 26.
Nelson, B.; Parnas, J.; Sass, L.A. Disturbance of minimal self (ipseity) in schizophrenia: Clarification and current status. Schizophr. Bull. 2014, 40, 479–482.
- 27.
Sass, L.; Parnas, J.; Zahavi, D. Phenomenological psychopathology and schizophrenia: Contemporary approaches and misunderstandings. Philos. Psychiatry Psychol. 2011, 18, 1–23.
- 28.
Sass, L.A. Self-Disturbance in Schizophrenia: Hyperreflexivity and Diminished Self-Affection; Cambridge University Press: Cambridge, UK, 2003. pp. 242–271.
- 29.
Parnas, J.; Jansson, L.; Sass, L.A.; et al. Self-experience in the prodromal phases of schizophrenia: A pilot study of first-admissions. Neurol. Psychiatry Brain Res. 1998, 6, 97–106.
- 30.
Moller, P.; Husby, R. The initial prodrome in schizophrenia: Searching for naturalistic core dimensions of experience and behavior. Schizophr. Bull. 2000, 26, 217–232.
- 31.
Nordgaard, J.; Handest, P.; Vollmer-Larsen, A.; et al. Temporal persistence of anomalous self-experience: A 5years follow-up. Schizophr. Res. 2017, 179, 36–40.
- 32.
Nordgaard, J.; Nilsson, L.S.; Saebye, D.; et al. Self-disorders in schizophrenia-spectrum disorders: A 5-year follow-up study. Eur. Arch. Psychiatry Clin. Neurosci. 2018, 268, 713–718.
- 33.
Parnas, J.; Handest, P.; Jansson, L.; et al. Anomalous subjective experience among first-admitted schizophrenia spectrum patients: Empirical investigation. Psychopathology 2005, 38, 259–267.
- 34.
Parnas, J.; Handest, P.; Saebye, D.; et al. Anomalies of subjective experience in schizophrenia and psychotic bipolar illness. Acta Psychiatr. Scand. 2003, 108, 126–133.
- 35.
Hur, J.W.; Kwon, J.S.; Lee, T.Y.; et al. The crisis of minimal self-awareness in schizophrenia: A meta-analytic review. Schizophr. Res. 2014, 152, 58–64.
- 36.
Stoychev, K.; Veleva, I.; Mineva-Dimitrova, E.; et al. Symptom severity and cognitive performance in patients with substance induced psychotic disorder and schizophrenia: A cross-sectional comparative study. Schizophr. Res. Cogn. 2025, 42, 100388. https://doi.org/10.1016/j.scog.2025.100388.
- 37.
De Risio, L.; Mosca, A.; Pasino, A.; et al. Anomalous self-experience in substance-induced and primary psychotic disorders: A cross-sectional comparative study using the EASE interview. Ann. Gen. Psychiatry 2025, 24, 72. https://doi.org/10.1186/s12991-025-00608-3.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Suite 4002 Level 4, 447 Collins Street, Melbourne, Victoria 3000, Australia
General Inquiries: info@sciltp.com